baber/WOPTO huggingface dataset:
Patent NZ-529198-A (NZ)
Title: Use of a sugar alcohol, sweetner and D-tagatose in improving the taste of zero- or low-calorie beverages and food products
Inventor: LEE THOMAS
IPC: A23L27/30
Filed: 2002-04-23
Abstract: Diet frozen carbonated, soft drink and fruit juice beverages comprise: (a) at least one non-nutritive sweetener; (b) erythritol in an amount of at least about 0.1% based on finished beverage weight; and (c) D-tagatose in an amount of at least about 0.1% based on finished beverage weight. Also described are methods of making the diet beverages and a sweetener composition comprising erythritol and D-tagatose. The composition imparts a taste substantially similar to full-calorie drinks to the beverages.
Patent NZ-530962-A (NZ)
Title: Alternative to viscose flocking and protective fabric coatings thereof
Inventor: HALL FREDERICK
IPC: D06M23/04
Filed: 2002-08-01
Abstract: A method of manufacturing a fabric coating, which is particularly relevant to crushed foam coatings, which simulates a viscose flocked finish is disclosed, which method, in relation to at least one layer of the fabric coating, includes the steps of providing fine beads of polymer which are hollow and partially filled with selected solvents or solvent blends or other volatile substances and adding these beads to a coating compound, which is a polymer for foaming, in its wet state and foaming the coating compound after the addition of the beads to it, coating the fabric with the resultant compound and oven drying the compound on the fabric and then raising the temperature of the coating to crosslink the polymer and expand the polymer beads within the coating layer. The disclosure also relates to a fabric coating and a coated fabric formed from this method.
Patent NZ-531175-A (NZ)
Title: Method for adding metadata to data
Inventor: BLOCK ROBERT S
IPC: G06F17/30
Filed: 2002-08-14
Abstract: A system comprises a computation device arranged to perform, in a collection of data and first metadata wherein the first metadata are associated with the data, identifying data in the collection based on the first metadata and one or more locations of the data and/or the first metadata in the collection; and adding second metadata to the collection based on the identified data. The identifying comprises identifying a first value in a first currency; and the computation device determines a second value in a second currency, based on the first value and a conversion factor. A system comprises a computation device arranged to perform, in a collection of data and first metadata wherein the first metadata are associated with the data, identifying data in the collection based on the first metadata and one or more locations of the data and/or the first metadata in the collection; and adding second metadata to the collection based on the identified data. The first metadata organize the identified data in accordance with a first standard; and the second metadata organize the identified data in accordance with a second standard.
Patent NZ-533143-A (NZ)
Title: Tissue array instrument with moving and releasing of punches automatically
Inventor: LEIGHTON STEPHEN B
IPC: G01N37/00
Filed: 2002-03-19
Abstract: Arrays of biological tissue can be created by removing cores from regions of interest in a series of donor blocks (16) of embedded tissues. The cores removed are placed in a regular array in a recipient block (15). This is typically done with two different punches, one for obtaining the cores of interest and the other for creating the receiving holes in the recipient block (15). The present invention comprises such a system including two separate z axes, one for each punch. Each punch has its own stylet and the axis of each punch is parallel to the axis of its drive. Alternatively, the invention is made by providing a single z axis, with a mechanism for automatically changing two or more punches in and out of a holder on the z axis. (62) Divided out of 528319
Patent NZ-533404-A (NZ)
Title: Frame, with jamb having grooves for locating architraves, for varying wall thicknesses
Inventor: RIRINUI BARRY RODERICK
IPC: E06B1/20
Filed: 2004-06-08
Abstract: The frame consists of a jamb 1 and L-shaped architraves 2,3 so as to allow for varying wall thicknesses.
Patent NZ-535642-A (NZ)
Title: Novel diazabicyclic biaryl derivatives
Inventor: PETERS DAN
IPC: A61P25/14
Filed: 2003-05-06
Abstract: Diazabicyclic biaryl derivatives of formula (I), which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters are disclosed, wherein the variables shown in formula (I) are as defined in the specification. Due to their pharmacological profile these compounds may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Patent NZ-538086-A (NZ)
Title: Continuous culture for multiplying conifer embryogenic tissue during the maintenance stage of somatic embryogenesis
Inventor: GUPTA PRAMOD K
IPC: C12N15/82
Filed: 2005-02-07
Abstract: A method for multiplying conifer embroyogenic tissue comprises continuously culturing conifer embryonic tissue in liquid multiplication medium for a period of time sufficient for the embryonic tissue to multiply.
Patent NZ-539671-A (NZ)
Title: 2-substituted 4-heteroarylpyrimidines suitable for treating diabetes, CNS disorders, alopecia, cardiovascular disorders and stroke
Inventor: WANG SHUDONG
IPC: A61K31/506
Filed: 2003-12-18
Abstract: The disclosure relates to the use of 2-substituted 4-heteroarylpyrimidine compounds of formula (I), or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating diabetes, wherein the variables shown in formula (I) are as defined in the specification. These compounds of formula (I) also have applications in the treatment of CNS disorders, alopecia, cardiovascular disorders and stroke.
Patent NZ-540132-A (NZ)
Title: A beam
Inventor: CHARLWOOD GRANT
IPC: E04C3/07
Filed: 2003-10-22
Abstract: A roll formed beam (40) of substantially rectangular cross-section formed from a unity piece of metal. The beam includes opposed first (44) and second (46) substantially parallel walls formed with at least three adjacent layers of said piece of metal (44 a, b, c, and 46 a, b, c). The beam (40) also includes opposed third (48) and fourth (50) substantially parallel walls between the first (44) and second (46) walls. One of the third (48) or fourth (50) walls has a seam (52) joining two opposed longitudinal edges of the piece of metal. A method of roll forming a beam (40) is also disclosed.
Patent NZ-542231-A (NZ)
Title: Soluble CTLA4 mutant fusion molecules and uses thereof
Inventor: PEACH ROBERT J
Filed: 2001-05-23
Abstract: Disclosed is a fusion protein comprising an extracellular domain of CTLA4 having one or more mutations in a region of i) an amino acid sequence which beings with serine at position +25 and ends with arginine at position +33 (S25-R33); and/or ii) an amino acid sequence which begins with methionine at position +97 and ends with glycine at position +107 (M97-G107), with the proviso that the one or more mutations do not consist of the double-site mutation of L104EA29Y. (62) Divided Out of 522031
Patent NZ-544386-A (NZ)
Title: Polypeptides with cellulose synthase GDP forming activity
Inventor: BLOKSBERG LEONARD N
IPC: C12N/
Filed: 2004-06-07
Abstract: Disclosed are isolated polynucleotides from Pinus Radiata that encode polypeptides with cellulose synthase activity and methods of producing a plant that expresses the cellulose synthase-encoding polynucleotides.
Patent NZ-546547-A (NZ)
Title: System and method to broadcast video with clear sound and picture using the internet to request transmission
Inventor: AL AMRI MOOSA E
IPC: H04N7/173
Filed: 2004-11-02
Abstract: A system for enabling video content to be selected by a user via the Internet and for distributing selected video content via a multichannel video broadcasting system, for the selected video content to be received on a multichannel receiver and displayed at the user's location on a TV monitor or on a PC provided with a TV display card is disclosed. The system comprises a main video server storing a plurality of selectable video contents; an authorization server accessible via the Internet for a user to transmit user commands to select video contents that are to be displayed immediately or with a delay; a multichannel video broadcasting apparatus; and a distribution server for supplying, from the main video server to the broadcasting apparatus, selected video contents to be broadcast on channels of the broadcasting apparatus. The system is arranged to provide an indication of a channel that is available to broadcast a selected video content immediately or with a delay in correspondence with a user command. The indication is available to the user via the authorization server and the Internet; and the system is arranged to initiate the broadcast of a selected video content on the indicated available channel immediately or with a delay in correspondence with the user command.
Patent NZ-547279-A (NZ)
Title: Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
Inventor: CREGG JAMES M
IPC: C12N15/74
Filed: 2004-10-22
Abstract: Disclosed are methods for the synthesis and secretion of recombinant hetero-multimeric proteins in mating competent yeast. A first expression vector is transformed into a first haploid cell; and a second expression vector is transformed into a second haploid cell. The transformed haploid cells, each individually synthesizing a non-identical polypeptide, are identified and then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric protein.
Patent NZ-548635-A (NZ)
Title: New combinations of an anti emetic agent and an enkephalinase inhibitor
Inventor: SCHWARTZ JEAN-CHARLES
IPC: A61K31/265
Filed: 2005-02-14
Abstract: Disclosed are combination of 5-HT3 receptor antagonist with racecadotril or dexecadotril. Also disclosed are uses of said combinations.
Patent NZ-549595-A (NZ)
Title: Silica-based sols and their production and use
Inventor: MANKIN GLENN
IPC: D21H17/68
Filed: 2005-04-05
Abstract: Disclosed is a process for producing an aqueous silica-based sol which comprises: (a) providing a cationic ion exchange resin having at least part of its ion exchange capacity in hydrogen form; (b) bringing said ion exchange resin in contact with an aqueous alkali metal silicate solution having a pH above 12 to form an aqueous slurry; (c) stirring said aqueous slurry to allow particle aggregation and microgel formation and until the pH of the aqueous phase is in the range of from 5.0 to 8.0; (d) adjusting the pH of said aqueous phase to above 9.0 by adding at least one alkaline material selected from aqueous alkali metal silicates, aqueous alkali metal hydroxides and ammonium hydroxide; and (e) separating said ion exchange resin from the aqueous phase after step (c) or after step (d).
Patent NZ-550045-A (NZ)
Title: Cytotoxicity mediation of cells evidencing surface expression of CD44
Inventor: YOUNG DAVID S F
IPC: C07K16/00
Filed: 2005-03-23
Abstract: Disclosed is the use of an isolated monoclonal antibody, or antigen binding fragment thereof, produced by the hybridoma cell line deposited with ATCC as accession number PTA-4621 for the manufacture of a medicament for the treatment of a breast tumor that is negative for Her2 expression.
Patent NZ-552037-A (NZ)
Title: Management of licence schemes for software products licences
Inventor: JACKSON WAYNE ALBERT
Filed: 2003-11-05
Abstract: A computer implemented method for determining software product licensing schemes for a customer is provided. The method includes the steps of receiving a software product license data from a sales database, collating the software product license data into an analysis database, retrieving data from the analysis database, retrieving customer requirement data, and calculating possible licence schemes based on the retrieved data and customer requirement data with includes intended deployment of software products over a specified time.
Patent NZ-552449-A (NZ)
Title: Dimensional analysis of saccharide conjugates with GPC & SEC-MALS
Inventor: CAPANNOLI GIORGIO
IPC: G01N30/02
Filed: 2005-06-21
Abstract: Provided is a composition comprising a conjugate of a capsular saccharide from serogroup A, C, W135, or Y of Neisseria meningitidis, wherein the conjugate has a specified molecular mass or size. Further provided are mixtures of the said compositions, plurality of batches of mixtures and batches of corresponding vaccines, as well as methods of producing them.
Patent NZ-561246-A (NZ)
Title: Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid
Inventor: BOYD EDWARD ANDREW
IPC: A61K31/4709
Filed: 2006-03-01
Abstract: Disclosed is a microcrystalline form of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid, wherein at least 90% of the crystals have a diameter not greater than about 3mm. Also disclosed is a process for the preparation of a microcrystalline form of (5-fluoro-2methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid as described above, the process comprising: i. treating crystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid with an aqueous weak base; and ii. treating the mixture with a weak acid; and iii. collecting the precipitated microcrystalline (5-fluoro-2-methyl-3-quinolin-2ylmethyl-indol-1-yl)-acetic acid. The use of the above microcrystalline form of (5-fluoro-2-methyl-3-quinolin-2ylmethyl-indol-1-yl)-acetic acid in the preparation of an agent for the treatment or prevention of allergic asthma, perennial allergic rhinitis, seasonal allergic rhinitis, atopic dermatitis, contact hypersensitivity (including contact dermatitis), conjunctivitis, especially allergic conjunctivitis, eosinophilic bronchitis, food allergies, eosinophilic gastroenteritis, inflammatory bowel disease, ulcerative colitis and Crohn's disease, mastocytosis and also other PGD2-mediated diseases, for example autoimmune diseases such as hyper IgE syndrome and systemic lupus erythematus, psoriasis, acne, multiple sclerosis, allograft rejection, reperfusion injury, chronic obstructive pulmonary disease, as well as rheumatoid arthritis, psoriatic arthritis and osteoarthritis and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, stroke and amyoptrophic lateral sclerosis is further disclosed.
Patent NZ-568763-A (NZ)
Title: Method for demethylating the 3'-dimethylamino group of erythromycin compounds
Inventor: LIU YAOQUAN
IPC: C07H17/08
Filed: 2006-11-01
Abstract: Disclosed is a method of preparing a compound (II) from a compound (I), wherein the substituents are as defined in the specification, comprising treating compound (I) with iodine in the presence of an amine having a pKb in the range between about 5 and about 6.
Patent NZ-569661-A (NZ)
Title: Therapeutic agent for diabetes
Inventor: TAKEUCHI KOJI
IPC: A61K31/513
Filed: 2006-12-27
Abstract: Disclosed is an agent, which comprises a blood glucose lowering drug that does not stimulate insulin secretion, and compound (I) or compound (II) in combination, wherein the compound (I) is a compound represented by the formula (I): wherein M is N or CR4; Q1, Q2, R2, X is defined in the specification. L is a linker providing a gap corresponding to 1, 2 or 3 atoms between X and the ring L is bonded to (the atom of the linker is selected from the group consisting of a carbon atom, an oxygen atom, a nitrogen atom and a sulfur atom or a salt thereof. Also disclosed is the use of said agent for pancreas protection.
Patent NZ-569791-A (NZ)
Title: Microaggregates including endothelial cells for microscopic observation
Inventor: WEISENTHAL LARRY MARK
IPC: C12N5/071
Filed: 2006-12-15
Abstract: Disclosed is a method to determine the effect of a treatment on viability of endothelial cells as compared to non-endothelial cells in a microaggregate. The method comprises (a) Contacting a composition comprising at least one microaggregate comprised of viable endothelial cells and viable non-endothelial cells with said treatment, (b) Adding a first indicator dye which is taken up by non-living cells and excluded by living cells; (c) Sedimenting said microaggregate onto a surface for microscopic observation; (d) Determining by microscopic observation the effect of said treatment on the viability specifically of endothelial cells in said microaggregate wherein non-viable endothelial cells are identified as hyperchromatic cells thus distinguishable from non-endothelial non-viable cells; A treatment that is determined to effect endothelial cell death is identified as successful in killing endothelial cells.
Patent NZ-573225-A (NZ)
Title: Charging mechanism for a needle-free injector with a piston actuator driven by a gas charge
Inventor: TOLES WARREN
IPC: A61M5/30
Filed: 2007-06-07
Abstract: Disclosed is a needle-free injection device for delivering a medicament under pressure from a dosing reservoir through an outlet orifice for administration to an animal or human. The device has a plunger slidably received in the dosing reservoir and movable in a forward direction for expelling the medicament through the orifice. The injection device includes an actuating device and the actuating device includes: (a) A gas tight chamber. (b) A piston and rod assembly slidably received in the chamber and movable between a forward position and a rearward position. (c) A gas charge in the chamber for urging the piston and rod assembly to the forward position. (d) A charging mechanism for moving the piston and rod assembly against the gas charge into the rearward position. The charging mechanism includes a threaded shaft threadingly engaged with a nut member that is operatively associated with the piston and rod assembly and moveable along a length of the threaded shaft when the threaded shaft is rotated. (e) A trigger for releasably retaining the piston and rod assembly in the rearward position. Activating the trigger causes the piston and rod assembly to be released for movement by the gas charge to the forward position so as to impact the plunger directly or indirectly with a force sufficient to cause the plunger to move in the forward direction to expel the medicament through the outlet. The gas tight chamber is adapted to minimize or prevent the escape of the gas charge so as to maintain the, gas charge in a pressurized state.
Patent NZ-579331-A (NZ)
Title: Utility monitoring device, system and method
Inventor: SALTER GEOFFREY DAVID VINCENT
IPC: G01R11/57
Filed: 2008-02-04
Abstract: A method of using a monitoring device for in-building monitoring of usage of a commodity supplied by a utility and contemporaneously displaying in-building at least two usage metrics and the monitoring device are disclosed. The monitoring device (100) comprises a receiver means for receiving information relating to at least a first of the two usage metrics; display means having a display area (110); light source means (118) and control means. The first usage metric relates to present consumption rate or aggregate consumption of the commodity. The light source means is for selectively illuminating at least part of the display area with light of a selected one of a plurality of colours and varying the illuminated area. The control means is responsive to the receiver means for controlling the light source means to select the illumination colour and to vary the illuminated area, the colour selection and area variation. Each of which are indicative of a respective one of the at least two usage metrics. Also disclosed is a plurality of the above described monitoring devices. These monitoring devices form a mesh or a point-to-point network supporting many-to-one, one-to-many or many-to-many communications. The above described monitoring device in combination with a transceiver adapter for mounting between an electricity meter and a receptacle for the electricity meter and communicating with the monitoring device remote therefrom is disclosed. The adapter comprises a set of connectors each for connecting a respective one of a set of terminals on the electricity meter to a corresponding one of a set of complementary terminals on the receptacle, and provide a conductive path for the power lines, a base having means for extracting current from line current carrying conductors within the adapter, means for deriving from the extracted current a signal representing present consumption; transmitter means responsive to the signal for transmitting to the monitoring device a further signal representing present consumption, and power supply means for extracting power from the lines to supply components in the adapter.
Patent NZ-579687-A (NZ)
Title: Whitening agent
Inventor: KATO KEN
IPC: A23K10/28
Filed: 2008-03-10
Abstract: 579687 Disclosed is a skin-whitening agent comprising, as an effective ingredient, a whey protein hydrolyzate having the following characteristics: (A) the molecular weight is distributed within 10 kDa with a main peak of 200 Da to 3 kDa; (B) the APL (average peptide-chain length) is 2 to 8; (C) the free amino acid content is 20% or less; and (D) the antigenicity is one-ten thousandth of antigencity of ?-lactoglobulin or less, wherein the whey protein hydrolyzate contained as the effective ingredient is obtained by enzymatically decomposing a whey protein while thermally denaturing the whey protein using a heat-resistant protein hydrolyzing enzyme under pH 6 to 10 at 50 to 70°C, then heating the obtained product and thereby deactivating the enzyme, and then concentrating the obtained product by using ultrafiltration (UF) membranes with a molecular weight cut off in a range of 1 kDa to 20 kDa. Further disclosed is the use of a whey protein hydrolyzate in the manufacture of a skin-whitening agent in the treatment of age spots and/or freckles, said whey protein hydrolyzate having the following characteristics: (A) the molecular weight is distributed within 10 kDa with a main peak of 200 Da to 3 kDa; (B) the APL (average peptide-chain length) is 2 to 8; (C) the free amino acid content is 20% or less; (D) the antigenicity is one-ten thousandth of antigenicity of b-lactoglobulin or less; and (E) the whey protein hydrolyzate is concentrated by using ultrafiltration (UF) membranes with a molecular weight cut off in a range of 1 kDa to 20 kDa.
Patent NZ-580045-A (NZ)
Title: Acidified liquid human milk supplement
Inventor: EUBER JOHN
IPC: A23L33/00
Filed: 2008-04-21
Abstract: Disclosed is a liquid human milk supplement comprising: a protein component; a fat component, wherein the fat component comprises greater than about 50% of the caloric content of the supplement; a carbohydrate component, wherein the carbohydrate component comprises less than about 10% of the caloric content of the supplement; vitamins; and minerals, wherein the pH of the human milk supplement is between 4.0 and 4.6.
Patent NZ-581574-A (NZ)
Title: Method of acupuncture and a needle for carrying out said method
Inventor: MUKHINA MARIAT MURADALIEVNA
IPC: A61H39/08
Filed: 2008-05-07
Abstract: Provided is an acupuncture needle with prolonged action, comprising a body; and two locking members, with at least one said locking member being slidable, wherein the at least one locking member is a detachable slidable locking member being securable on the body, wherein the body is plastic deformable to form flat sections to affix the needle to an assigned position. Needle can be rigid or flexible and made of a metallic alloy of gold, silver and copper.